Cite
Sepp-Lorenzino L, Tjaden G, Moasser MM, et al. Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancer. Prostate Cancer Prostatic Dis. 2001;4(1):33-43doi: 10.1038/sj.pcan.4500491.
Sepp-Lorenzino, L., Tjaden, G., Moasser, M. M., Timaul, N., Ma, Z., Kohl, N. E., Gibbs, J. B., Oliff, A., Rosen, N., & Scher, H. I. (2001). Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancer. Prostate cancer and prostatic diseases, 4(1), 33-43. https://doi.org/10.1038/sj.pcan.4500491
Sepp-Lorenzino, L, et al. "Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancer." Prostate cancer and prostatic diseases vol. 4,1 (2001): 33-43. doi: https://doi.org/10.1038/sj.pcan.4500491
Sepp-Lorenzino L, Tjaden G, Moasser MM, Timaul N, Ma Z, Kohl NE, Gibbs JB, Oliff A, Rosen N, Scher HI. Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancer. Prostate Cancer Prostatic Dis. 2001;4(1):33-43. doi: 10.1038/sj.pcan.4500491. PMID: 12497061.
Copy
Download .nbib